المؤلفون: Tomaniak, M. (Mariusz), Chichareon, P. (Ply), Takahashi, K. (Kuniaki), Kogame, N. (Norihiro), Modolo, R. (Rodrigo), Chang, C.C. (Chun Chin), Spitzer, E. (Ernest), Neumann, F.J., Plante, S. (Sylvain), Hernandez-Antolin, R. (Rosana), Jambrik, Z. (Zoltan), Gelev, V. (Valeri), Brunel, P. (Philippe), Konteva, M. (Mariana), Beygui, F. (Farzin), Morelle, J.-F. (Jean-Francois), Filipiak, K.J. (Krzysztof J.), Geuns, R.J.M. (Robert Jan) van, Soliman, O.I.I. (Osama Ibrahim Ibrahim), Tijssen, J.G.P. (Jan), Rademaker-Havinga, T.A.M. (Tessa), Storey, D. (David), Hamm, C. (Christian), Steg, P.G. (Philippe Gabriel), Windecker, S.W. (Stephan), Onuma, Y. (Yoshinobu), Valgimigli, M. (Marco), Serruys, P.W.J.C. (Patrick)

المصدر: European heart journal. Cardiovascular pharmacotherapy vol. 6 no. 4, pp. 222-230

مصطلحات موضوعية: Aspirin-free antiplatelet strategies after percutaneous coronary intervention, Chronic obstructive pulmonary disease, Dyspnoea adverse event, Percutaneous coronary intervention, Ticagrelor

وصف الملف: application/pdf

Relation: http://repub.eur.nl/pub/129112; urn:hdl:1765/129112

الاتاحة: http://repub.eur.nl/pub/129112
https://doi.org/10.1093/ehjcvp/pvz052